Advanced

Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group

Nielsen, Dorte Lisbet; Bjerre, Karsten D.; Jakobsen, Erik H.; Cold, Søren; Stenbygaard, Lars; Sørensen, Peter G.; Kamby, Claus; Møller, Susanne; Levin Tykjaer Jörgensen, Charlotte LU and Andersson, Michael (2011) In Journal of Clinical Oncology 29(36). p.4748-4754
Please use this url to cite or link to this publication:
author
publishing date
type
Contribution to journal
publication status
published
in
Journal of Clinical Oncology
volume
29
issue
36
pages
4748 - 4754
publisher
American Society of Clinical Oncology
external identifiers
  • scopus:84555218405
ISSN
0732-183X
DOI
10.1200/JCO.2010.33.9507
language
English
LU publication?
no
id
67be86dc-4fea-4b27-8e4e-1c24c5fd4e66
date added to LUP
2017-04-18 14:30:08
date last changed
2017-04-23 04:59:50
@article{67be86dc-4fea-4b27-8e4e-1c24c5fd4e66,
  author       = {Nielsen, Dorte Lisbet and Bjerre, Karsten D. and Jakobsen, Erik H. and Cold, Søren and Stenbygaard, Lars and Sørensen, Peter G. and Kamby, Claus and Møller, Susanne and Levin Tykjaer Jörgensen, Charlotte and Andersson, Michael},
  issn         = {0732-183X},
  language     = {eng},
  number       = {36},
  pages        = {4748--4754},
  publisher    = {American Society of Clinical Oncology},
  series       = {Journal of Clinical Oncology},
  title        = {Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group},
  url          = {http://dx.doi.org/10.1200/JCO.2010.33.9507},
  volume       = {29},
  year         = {2011},
}